Know your world in 60 words - Read News in just 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2021-08-02 15:20:14

A recent study by the Indian Council of Medical Research reveals that Bharat Biotech's Covaxin is effective against the rampant Delta Plus variant of COVID-19. Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) National Institute of Virology (NIV). Earlier, Bharat Biotech had said that Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

A recent study by the Indian Council of Medical Research reveals that Bharat Biotech's Covaxin is effective against the rampant Delta Plus variant of COVID-19. Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) National Institute of Virology (NIV). Earlier, Bharat Biotech had said that Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

Editor & Publisher : Dr Dhimant Purohit

Headlines

Good News

politics

India

World